B

Biointellisense

Wearable remote patient monitoring with analytics

Vice President, Growth

Full-Time
$200k - $250k/yr+ 401(k) employer contribution + Home office benefits stipend
Expert
Remote in USA
RemoteAt least 25% travel to customer sites is expected.
Sales & Account ManagementAccount Management

About the job

Requirements
  • 10+ years in commercial roles selling into and expanding within large health systems and integrated delivery networks, including 5+ years in customer-facing roles.
  • A demonstrated land-and-expand track record in healthcare program adoption, personally taking accounts from initial deployment to enterprise scale.
  • Credibility with both frontline hospital staff and C-suite executives, including chief nursing, medical, and financial officers.
  • Ability to build and defend pro forma financial models covering nursing labor, length of stay, readmissions, rapid response and code events, and applicable reimbursement.
  • Experience building a commercial account management or customer success function from an early stage, including recruiting, onboarding, and establishing operating rhythms.
  • A track record of turning stalled or at-risk accounts into expanding accounts.
  • Rigorous operating discipline with current and trusted account plans, stakeholder maps, and forecasts.
  • Willingness to travel to customer sites, with at least 25% travel expected.
Responsibilities
  • Take new customers who have executed contracts from phase-one go-live through market and eventual system-wide adoption.
  • Own post-go-live growth across adoption, escalation, expansion, and renewal for the installed base.
  • Build and run a repeatable expansion playbook that moves customers through enterprise deployment using proof points for economic, clinical, and operational stakeholders.
  • Establish floor-to-executive exception handling for top accounts and build the process and organization supporting product roadmap input, clinical solution design, and stakeholder management.
  • Travel onsite to customers and cultivate relationships to support program scaling.
  • Carry expansion and renewal commercial targets across the installed base.
  • Lead expansion planning and value proposition delivery, aligning pro forma return-on-investment models with program design and change management alongside clinical and finance stakeholders.
  • Own executive relationships and executive business reviews, including the handoff from new-business sales into the post-sale relationship.
  • Design customer-specific value realization programs tying clinical objectives to phased expansion paths and measurable outcomes.
  • Hire, build, and lead a commercial account management function accountable for adoption, expansion, and renewal within named accounts.
  • Define the account team's coverage model, expansion stage gates, forecast discipline, and working rhythm with Clinical Success and Implementation.
  • Build and maintain stakeholder maps across clinical, operational, financial, and information technology functions in every account.
  • Partner with Clinical and Product teams to ensure workflow issues reach accountable owners and are resolved.
  • Bring evidence-based customer friction to Product and hold both teams accountable for resolution.
  • Work with channel and distribution partners to convert partner-sourced opportunities into deployed, expanding accounts.
Desired Qualifications
  • Clinical training or background with direct experience in remote patient monitoring, continuous monitoring, clinical surveillance, virtual nursing, or hospital-at-home.
  • Deep operational fluency in inpatient nursing workflow and how monitoring programs are staffed and sustained on a unit.
  • Experience selling with or through a large medical device channel partner.
  • Experience building a value realization or customer outcomes practice that translates clinical results into commercial expansion.
  • Familiarity with reimbursement for remote monitoring, including remote patient monitoring and remote therapeutic monitoring coding.
  • Experience standing up a clinical command center or centralized monitoring operation.

About the company

BioIntelliSense makes remote patient monitoring possible with its BioButton wearable, which continuously tracks vital signs to support at-home care. The device is designed to be comfortable and discreet, and it sends data to analytics that help clinicians spot early signs of health issues for proactive intervention. It primarily serves hospitals, health systems, provider organizations, and payors in the U.S. and select global markets, selling wearables and providing data analytics services. Its approach centers on cost-effectiveness, ease of use, and healthcare partnerships to improve patient outcomes while reducing costs from hospital stays and emergency care.

Company Size

51-200

Company Stage

Series B

Total Funding

$82M

Headquarters

Golden, Colorado

Founded

2018

Get referred to Biointellisense

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Houston Methodist reported a 27% relative mortality reduction in February 2026.
  • BioIntelliSense’s February 2025 Hicuity Health partnership expands managed monitoring for hospital-at-home programs.
  • FDA clearance of the rechargeable BioButton Multi-Patient in October 2024 unlocks reusable unit economics.

What critics are saying

  • Medtronic acquired BioIntelliSense in 2025, ending independent employer upside for applicants.
  • Employee count fell from 121 in 2025 to 101 in 2026, signaling contraction.
  • Telemetry incumbents and hospital command-center vendors can bundle similar monitoring into existing contracts.

What makes Biointellisense unique

  • FDA-cleared BioButton Multi-Patient scales continuous inpatient monitoring across 2,653 Houston Methodist beds.
  • BioDashboard combines minute-level biometrics with analytics, reducing manual spot-check nursing workflows.
  • iRhythm’s exclusive license for BioIntelliSense patents validates its multiparameter sensor IP.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • HSA and Flexible Spending Accounts
  • Safe Harbor 401(k) Plan with 3% Employer Contribution with immediate vesting
  • Flexible Vacation Plans
  • Sick Leave
  • 11 Company Holidays
  • Home Office Benefits Stipend

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

3%

2 year growth

5%
Castle Placement
Jan 8th, 2026
Top 10 Healthcare Devices and Supplies Capital Raises and Investors in the U.S. - November 16th to December 31st, 2025

Top 10 Healthcare Devices and Supplies capital raises and investors in the U.S. - november 16th to december 31st, 2025. Several interesting transactions closed in the Healthcare Devices and Supplies sector over the past month. If you would like more info or would like to discuss the capital raising market for your company, please contact me. * Positron, medical technology company that engages in the development, manufacturing, and sales of PET and PET-CT molecular imaging systems for nuclear medicine providers across North America, received $2 million of development capital from investors. * TELA Bio, commercial-stage medical technology that provides innovative soft-tissue reconstruction solutions and optimizes clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy, received $4.65 million of development capital from EW Healthcare Partners and Nantahala Capital Management. * Alerje, health technology solution for individuals with severe food allergies, was acquired by SemPresto. * Applied Tissue Technologies, wound care technologies that offer treatment of common acute and chronic wounds, was acquired by New Horizon Medical Solutions. * BioIntelliSense, remote patient monitoring device that enhances healthcare delivery, raised $58.05 million of venture funding. * eLux Medical, fat removal technology that disrupts the cosmetic surgery market, raised $11.28 million through a combination of Series B and Series B-1 venture funding from investors, putting the company's pre-money valuation at $12 million. * Entirety Biomedical, high-performance absorbable metal implants that improve the quality of life with advanced bioabsorbable implant technology, raised $1.2 million of venture funding in a deal led by NuFund Venture Group, putting the company's pre-money valuation at $8.8 million. * OrthoPreserve, meniscus implant device that replaces the damaged meniscus to relieve pain, restore mobility, and prevent the accelerated arthritis development that normally accompanies a meniscectomy, raised $157,000 of venture funding in the form of convertible debt financing from investors. * RedDrop Dx, device that allows blood collection to be done quickly, painlessly, and without a trained professional, raised $7 million of seed funding in a deal led by Phase Three Product Development, Stout Street Capital and Innosphere Ventures Fund. * TYBR Health, collagen-based resorbable hydrogel that protects healing tendons and ligaments and support recovery after surgery, raised $7.14 million through a combination of Seed Prime-1 and Seed Prime-2 funding from Johnson & Johnson Innovation - JLABS, Texas Medical Center and VentureSouq, putting the company's pre-money valuation at $9.66 million. Tamara williams. Managing director. Please contact me if you have any questions or would like to discuss your capital raise:

HIT Consultant
Feb 17th, 2025
AI-Powered Monitoring Meets 24/7 Virtual Care: BioIntelliSense and Hicuity Health Collaboration

- BioIntelliSense's FDA-cleared BioButton(R) wearable and BioDashboard(TM) clinical intelligence system will integrate with Hicuity Health's 24/7 virtual patient monitoring services.

HIT Consultant
Feb 17th, 2025
Ai-Powered Monitoring Meets 24/7 Virtual Care: Biointellisense And Hicuity Health Collaboration

What You Should Know:– BioIntelliSense, a leader in continuous health monitoring and clinical intelligence, and Hicuity Health, a leading provider of tech-enabled virtual care services, today announced a strategic partnership to offer fully managed, end-to-end continuous patient monitoring to hospitals and health systems.– This partnership addresses critical infrastructure and staffing challenges faced by hospitals and health systems, empowering them to deploy proven, scalable monitoring solutions for in-hospital care, hospital-at-home programs, post-hospital discharge and chronic remote care management.BioIntelliSense and Hicuity Health Partner to Enhance Continuous Patient MonitoringBioIntelliSense is transforming continuous health monitoring and clinical intelligence for virtual care and remote patient monitoring (RPM) across in-hospital and home settings. Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multiparameter vital signs and physiological biometrics, offering an effortless user experience. The FDA-cleared BioButton® wearable, BioHub® gateways, BioMobile™ applications, BioCloud™ data services, and BioDashboard™ clinical intelligence system together create a scalable, reliable solution for continuous patient monitoring. AI-driven analytics provide clinicians with high-resolution patient trends and data-driven insights, enabling improved and safer care.Strategic Partnership with Hicuity Health·       BioIntelliSense’s FDA-cleared BioButton® wearable and BioDashboard™ clinical intelligence system will integrate with Hicuity Health’s 24/7 virtual patient monitoring services.·       This integration provides nurses and clinicians with actionable health insights and improved workflow efficiencies.·       Hicuity Health’s services, delivering over 11 million hours of patient monitoring annually, reduce workforce burden and enhance high-acuity patient care.Advancing Scalable Continuous Care·       “The combination of BioIntelliSense’s award-winning, medical-grade solution with Hicuity Health’s expertise ensures that health systems of all sizes can deploy and scale continuous care programs efficiently,” said James Mault, MD, CEO and Founder of BioIntelliSense.·       The partnership addresses staffing challenges in health systems by providing a comprehensive, technology-enabled solution that enables earlier interventions, improves patient outcomes, and optimizes clinical resource utilization.Enhanced Virtual Care Capabilities·       The rechargeable, wireless BioButton® wearable continuously and passively monitors patient vital signs and biometrics, automating 1,440 measurements per patient per day.·       The BioDashboard clinical intelligence engine utilizes algorithmic-based analytics to track vital sign trends, securely monitored by Hicuity Health.·       Hicuity Health’s clinical teams follow predefined workflows and escalation protocols in collaboration with health systems to ensure timely interventions and better patient outcomes.This collaboration offers hospitals and health systems an effective solution to initiate or expand their virtual care programs, enhancing efficiency, scalability, and patient care quality

TipRanks
Sep 4th, 2024
iRhythm signs exclusive license agreement with BioIntelliSense

iRhythm Technologies announced that the company has signed an exclusive license agreement with BioIntelliSense, a continuous health monitoring and clinical intelligence company, to develop and commercialize certain patented technology assets within ambulatory cardiac monitoring, ACM.

StreetInsider
Sep 4th, 2024
iRhythm Technologies (IRTC) Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring

iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has signed an exclusive license agreement with BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, to develop and commercialize certain patented technology assets within ambulatory cardiac monitoring (ACM).